New York legislative agenda & upcoming votes New York session calendar
Summary
Relates to preserving access to affordable drugs; provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical product, shall be presumed to have anticompetitive effects if a nonreference drug filer receives anything of value from another company asserting patent infringement and if the nonreference drug filer agrees to limit or forego research, development, manufacturing, marketing, or sales of the nonreference drug filer's product for any period of time.
- A 8576 is a bill in the New York Assembly, 2025-2026 session, introduced May 21, 2025.
- Sponsored by Anna Kelles, with 27 cosponsors.
- Current status: introduced.
- Most recent action (January 7, 2026): REFERRED TO HEALTH.
-
State Representative, District 125
Democratic/Working Families
Contact your legislator about this bill
Bill text & documents
Sponsors
Primary: Anna Kelles
Cosponsors (27): Jonathan Rivera, Maritza Davila, Chris Burdick, Jo Anne Simon, Harvey Epstein, Linda Rosenthal, Donna Lupardo, Jessica Gonzalez-Rojas, Amy Paulin, Rodneyse Bichotte Hermelyn, Phil Steck, Albert A. Stirpe, Doug Smith, Karines Reyes, Phara Souffrant Forrest, Charles Lavine, Chantel Jackson, Andrew Hevesi, Jeffrey Dinowitz, Zohran Mamdani, Deborah Glick, Angelo Santabarbara, Steve Stern, Dana Levenberg, Amanda Septimo, Judy Griffin, Rebecca Kassay
History
- Introduced, completed
- Passed Assembly, in progress
- Passed Senate, not reached yet
- Sent to Governor, not reached yet
- Signed into law, not reached yet
- Assembly REFERRED TO HEALTH
- Assembly REFERRED TO HEALTH Latest